Assessment of echocardiographic measurement of right ventricular-pulmonary arterial coupling in the ICU patients
Emine Ünal Ceran,Gül Gürsel,Osman Tamer Şahin,Merve Tatlıoğlu,Serra Duygulu
DOI: https://doi.org/10.1016/j.jcrc.2024.154717
IF: 4.298
2024-04-01
Journal of Critical Care
Abstract:Introduction and aim Right ventricular(RV)-pulmonary arterial(PA) coupling shows ventricular contractility to afterload and quantifies the response of the right ventricle to an increased pulmonary pressure. In a compensated state, RV contractile function is coupled with pulmonary pressure and increases with an increase in pulmonary afterload. Uncoupling of RV function and PA systolic pressure (PASP) has consistently been associated with adverse clinical outcomes in various conditions, including heart failure, PH, and valvular heart disease. As a noninvasive echocardiographic equivalant of RV-PA coupling TAPSE/PASP ratio was found to be more useful than TAPSE in predicting the prognosis of pulmonary hypertension, it was recommended instead of TAPSE in the 2022 pulmonary hypertension guideline. A ratio below 0.55 is considered low, while a ratio below 0.35 is considered a poor prognostic factor. The aim of the study is to investigate the relationship between RV failure and TAPSE/PASP ratio and prognosis in ICU patients. Patients and methods 140 patients were included in this retrospective study. The relationship of the TAPSE/PASP ratio of the patients with cardiac USG parameters, mechanical ventilation treatment (MV), obesity, COPD, ejection fraction (EF), early diastolic mitral inflow velocity (E), early diastolic septal mitral annular tissue velocity (e′), and the ratio of (E/e'), mortality, home oxygen therapy (LTOT) and noninvasive ventilation (NIV) therapy were investigated. To diagnose RV failure tricuspid annular plane systolic excursion (TAPSE) < 16 mm, Fractionate area change (FAC) < 35% criteria were used. Results While the TAPSE/PASP ratio was not associated with MV treatment, obesity, COPD, EF, and mortality, it was found significantly lower in patients with E/e' > 14(0.43 + 0.21 & 0.88 + 0.73, p: 0.001) receiving LTOT (0.60 + 0.43 &0.90 + 0.77, p:0.041) and home NIV therapy (0.48 + 0.28 & 0.94 + 0.77, p:0.002). According to TAPSE and FAC, 30% and 22% of the patients had RV failure respectively, while 53% of patients had TAPSE/PASP <0.55 and 30% <0.35. Conclusion TAPSE/PASP ratio was found to be significantly lower in patients with chronic respiratory failure using LTOT and home NIV therapy and diastolic dysfunction (E/e' > 14) and reflected RV distress better than TAPSE and FAC. References 1-Vanderpool RR, Pinsky MR, Naeije R, et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 2015;101:37–43.
critical care medicine